Background/Aims: Keratinocyte growth factor (KGF) plays a critical role in prevention of cirrhosis and enhancement of liver regeneration. However, the molecular regulation of KGF in liver is unknown. MicroRNAs (miRNAs) control the pathogenesis of cirrhosis, whereas the exact involved miRNAs and molecular signaling pathways remain ill-defined. Here we addressed these questions. Methods: We examined the correlation of the levels of miR-219-5p and KGF in the liver biopsies from patients with liver diseases. The effects of overexpression or suppression of miR-219-5p on KGF were examined in both human and mouse hepatic stellate cells (HSCs). Bioinformatics analysis was applied to examine the binding of human/ mouse miR-219-5p to the 3'-UTR of human/mouse KGF mRNA, respectively. Finally, adenoassociated viruses carrying antisense of miR-219-5p were infused into the liver from the mice that had developed cirrhosis by carbon tetrachloride (CCl 4 ), and the effects on KGF levels and liver damage and function were examined. Results: The levels of miR-219-5p and KGF in the liver biopsies were inversely correlated. MiR-219-5p inhibited KGF expression in both human and mouse HSCs, through directly binding the 3'-UTR of KGF mRNA. Expression of antisense of miR-219-5p significantly attenuated the levels of liver fibrosis, portal hypertension and sodium retention caused by CCl 4 . Conclusions: Suppression of miR-219-5p may benefit the liver regeneration and prevent cirrhosis through increasing KGF.
Introduction
More than 200 million people worldwide are estimated to be infected by Hepatitis C virus, which leads to development of chronic non-A non-B hepatitis, a disease that often finalizes into cirrhosis and hepatic cancer [1] . The pathological processes of cirrhosis include injury-induced chronic inflammation, portal hypertension due to impaired blood flow, and disruption of normal hepatic architecture [2, 3] . Then, liver dysfunction occurs as a result.
Among all animal models that have been used for studying cirrhosis, carbon tetrachloride (CCl 4 ) intraperitoneal injection model is a very commonly used one, since it is low toxic to mice and appears to be highly reproducible [4] [5] [6] [7] [8] [9] . Previous studies on the molecular mechanism underlying the development of cirrhosis have shown that keratinocyte growth factor (KGF) [10] , which is predominantly produced and secreted by hepatic stellate cells (HSCs) [11] , plays a critical role in the prevention of cirrhosis and enhancement of liver regeneration [11, 12] . KGF is a member from fibroblast growth factor (FGF) family and is known as FGF7 [10] . KGF is a potent mitogen for different types of epithelial cells, in which it regulates migration and differentiation of epithelial cells upon stress [10] . KGF exerts its biological effects via binding to its high-affinity receptor, a splice variant of FGF receptor 2 (FGFR2-IIIb), in epidermal keratinocytes, intestinal epithelial cells and hepatocytes [13] . Thus, KGF acts predominantly in a paracrine manner. Importantly, KGF expression is strongly up-regulated after acute injury to various tissues, including skin, bladder, kidney and liver [14] .
MiRNAs are small RNA species that range from 19 to 25 nucleotides in length, and are often found to be dysregulated in various diseases [15] [16] [17] . Recent findings have implicated the involvement of miRNAs in the HCV infection and development of cirrhosis [1-3, 18, 19] . These studies have shown upregulation of a number of miRNAs in the fibrotic liver, which may imply a possible involvement of miRNAs in the pathogenesis of cirrhosis. However, the exact underlying regulatory molecular pathways have not been completely elucidated.
Here, we examined the correlation of the levels of miR-219-5p and KGF in the liver biopsies from patients with liver diseases. The effects of overexpression or suppression of miR-219-5p on KGF were examined in both human and mouse HSCs. Bioinformatics analysis was applied to examine the binding of human/mouse miR-219-5p to the 3'-UTR of human/ mouse KGF mRNA, respectively. Finally, adeno-associated viruses carrying antisense of miR-219-5p was infused into the liver from the mice that had developed cirrhosis by CCl 4 , and the effects on KGF levels and liver damage and function were examined.
Materials and Methods
Specimens from patients A total of 23 liver biopsies from cases with liver diseases were used in this study. All the patients were clinically diagnosed at Chinese PLA General Hospital from 2010 to 2015. All patients gave signed, informed consent for the tissue to be used for scientific research. Ethical approval for the study was obtained from Chinese PLA General Hospital. All diagnoses were based on pathological and/or cytological evidence. The histological features of the specimens were evaluated by senior pathologists according to the World Health Organization classification criteria.
Isolation of human and mouse HSCs
HSCs from human donor or mouse liver were separated from non-parenchymal liver cells by arabinogalactan gradient ultracentrifugation, as has been previously described [20] . The procedure yielded HSCs that were more than 85% pure and 90% viable, as determined by phase contrast and UV-excited fluorescence microscopy by the aid of trypan blue exclusion. HSCs were cultured in Dulbecco's modified Eagle's medium (DMEM, Life Technologies, San Jose, CA, USA) supplemented with 10% heat-inactivated fetal calf serum (Invitrogen, Carlsbad, CA, USA), 100 IU/ml penicillin, and 100 µg/ml streptomycin in a 95% air and 5% CO 2 -humidified atmosphere. Growth medium was changed daily during the first 4 days in culture and every second day thereafter.
Plasmids and adeno-associated virus (AAV) preparation
Plasmids were successfully constructed using molecular cloning technology. Target sequences [miR-219-5p, miR-219-5p antisense (as-miR-219-5p), and null sequence] were inserted into pGL3-Basic vector (Promega, Beijing, China) for preparation of AAV, as has been previously described [21] [22] [23] . A pAAV-CAG-GFP plasmid was used as a backbone (Clontech, Mountain View, CA, USA) to generate AAV. As-miR-219-5p and miR-219-5p were cloned using EcoRIII and NheI restriction endonucleases sites in the backbone plasmid. The plasmid also has a GFP reporter. The inserted constructs were connected with GFP with a 2A sequence, which allows for efficient, stoichiometric production of discrete protein products within a single vector through a novel "cleavage" event. Sequencing was performed to confirm the correct orientation of these new plasmids. AAV was prepared by triple transfection of the prepared AAV plasmids, R2C8 (containing AAV8 capsid genes) and plAd5 (containing adenovirus helper genes) (Applied Viromics, LLC. Fremont, CA, USA) into HEK293 cells (ATCC) by Lipofectamine 2000 reagent (Invitrogen). The viruses were purified using CsCl density centrifugation and then titered by a quantitative densitometric dot-blot assay.
Luciferase-reporter activity assay
MiRNAs targets were predicted with the algorithms TargetScan, as previously described [24] . The candidates were analyzed for context+ score, which is the sum of the contribution of 6 features (including site-type contribution, 3' pairing contribution, local AU contribution, position contribution, TA contribution and SPS contribution). The KGF 3'-UTR reporter plasmid (pRL-KGF) and the KGF 3'-UTR reporter plasmid with a mutant at miR-219-5p binding site (pRL-KGF-mut) were purchased from Creative Biogene (Shirley, NY, USA). HSCs were collected 36 hours after transfection for dual-luciferase reporter assay (Promega), according to the manufacturer's instructions.
Animal manipulations
All animal procedures were conducted according to the guidelines for the care and use of laboratory animals approved by Chinese PLA General Hospital. Female C57BL/6 mice (Charles River Laboratories, China) of 10 weeks of age were given free access to tap water and pelleted mouse diet. Cirrhosis was induced by CCl 4 intraperitoneal administration. Briefly, CCl 4 solution of 50% (v/v) in paraffin oil (Sigma-Aldrich, St. Louis, MO, USA) was administered at a dose of 2ml/kg body weight of the mice, by intraperitoneal injections twice a week for 8 weeks. Each experimental group contained 10 mice. During cirrhosis induction, the mice were provided with 0.3 g/l phenobarbital in drinking water to enhance CCl 4 hepatotoxicity.
Liver infusion with AAV-as-miR-219-5p
Liver infusion with AAV carrying as-miR-219-5p or AAV-null was performed as has been described before [25] [26] [27] [28] . Briefly, the duodenum was exposed to show the common bile duct, after which a microclamp was placed on the common bile duct close to gallbladder. A 31-gauge blunt-ended catheter was then put into the common bile duct through the sphincter of Oddi in the duodenum till the branching of the left and right hepatic duct, which was then clamped with another microclamp to prevent backflow into pancreas and duodenum. The other end of the catheter is connected to a micro-infusion apparatus, which delivers 200μl of AAV containing 10 10 AAV-as-miR-219-5p viral particles, or control AAV-null viral particles, via the catheter at a rate of 5μl/min. After infusion, the hole created by the catheter in the duodenum was closed with 6-0 gauge suture.
Evaluation of liver fibrosis
Liver samples were fixed in 10% phosphate-buffered formalin, embedded in paraffin, and stained with the Sirius red staining technique, which stains collagen. Fibrotic areas were counted on 200 random selected fields corresponding to approximately 6mm 2 , using an unbiased counting frame, as has been described previously [14] . The percentage of fibrotic area was expressed as a number of fibrotic fields divided by total fields, and then multiplied by 100.
Sodium balance
The urine sodium concentration (UNa) was assayed by flame photometry (Roika 2000, Roika, UK), and renal sodium excretion (UNaV) was calculated with the following formula: UNaV = UV × UNa, where UV is urine volume. The intake of sodium was assessed by measuring the amounts of food and water consumed. Sodium balance was calculated as (Na+ provided by food and water)-UNaV.
Statistical analysis
Statistical analyses were performed with SPSS 19.0 software (SSPS Inc., Chicago, IL, USA). All data were statistically analyzed using one-way ANOVA with a Bonferroni correction, followed by Fisher's Exact Test for comparison of two groups. All values are depicted as mean ± standard deviation, and are considered significant if p < 0.05. Each group contained 10 individuals. Bivariate correlations were calculated by Spearman's r.
Results

KGF and miR-219-5p inversely correlate in the liver biopsies
Here, we studied whether KGF may be regulated by any miRNAs. Using liver specimens, we specifically detected an inverse correlation between the levels of miR-219-5p and KGF (Fig. 1, r=0 .73, p<0.001). These data suggest that there may be a causal relationship between miR-219-5p and KGF in liver.
MiR-219-5p suppresses KGF in both human and mouse HSCs
Previous studies have shown that KGF is predominantly produced and secreted by HSCs in liver. Thus, we isolated human and mouse HSCs. First, we either overexpressed hsa-miR-219-5p or as-hsa-miR-219-5p in human HSCs by AAV-mediated transduction. Modulation of hsa-miR-219-5p levels by AAVs in Human HSCs was confirmed by RT-qPCR ( Fig. 2A) . We found that KGF levels in miR-219-5p-overexpressing cells were significantly decreased, while KGF levels in miR-219-5p-depleted cells were significantly increased, as measured by RT-qPCR (Fig. 2B) , and by ELISA on cellular protein (Fig. 2C) . Next, we either overexpressed mms-miR-219-5p or as-mms-miR-219-5p in mouse HSCs by AAV-mediated transduction. Modulation of mms-miR-219-5p levels by AAVs in mouse HSCs was confirmed by RT-qPCR (Fig. 2D) . We found that KGF levels in miR-219-5p-overexpressing cells were significantly decreased, while KGF levels in miR-219-5p-depleted cells were significantly increased, as to 261 st base site (Fig. 3A) , while mms-miR-219-5p bound to 3'-UTR of mouse KGF mRNA sequence ranged from 262 nd to 268 th base site (Fig. 3B) . Next, the intact 3'-UTR of human KGF mRNA (KGF 3'-UTR), together with a 3'-UTR with mutant at miR-219-5p-binding site of human KGF mRNA (KGF 3'-UTR mut), was then cloned into luciferase reporter plasmids. Human HSCs were co-transfected with 1μg miR-219-5p/null/as-miR-219-5p plasmids and 1μg human KGF 3'-UTR or human KGF 3'-UTR mut plasmids, after which the luciferase activity was measured (Fig. 3C) . Finally, the intact 3'-UTR of mouse KGF mRNA (KGF 3'-UTR), together with a 3'-UTR with mutant at miR-219-5p-binding site of mouse KGF mRNA (KGF 3'-UTR mut), was then cloned into luciferase reporter plasmids. Mouse HSCs were cotransfected with 1μg miR-219-5p/null/as-miR-219-5p plasmids and 1μg mouse KGF 3'-UTR or mouse KGF 3'-UTR mut plasmids, after which the luciferase activity was measured (Fig.  3D) . The results demonstrated that miR-219-5p specifically targeted 3'-UTR of KGF mRNA to inhibit its translation in both human and mouse HSCs (Fig. 3C-D) . 4 In order to evaluate the inhibitory effect of miR-219-5p on KGF in vivo, we injected CCl 4 to induce cirrhosis in mice. Afterwards, the mice received hepatic infusion with AAV-as-miR-219-5p or AAV-null as a control, through common bile duct. The mice were then kept for another 4 weeks before analyses (Fig. 4A) .
As-miR-219-5p significantly increases KGF in mouse liver after CCl
The infection of the mouse liver by AAVs was demonstrated by GFP expression resulting from the presence of a GFP reporter in both AAV-as-miR-219-5p and AAV-null (Fig. 4B) . The knockdown of miR-219-5p in liver was confirmed by RT-qPCR on liver samples (Fig. 4C) . The intact 3'-UTR of human KGF mRNA (KGF 3'-UTR), together with a 3'-UTR with mutant at miR-219-5p-binding site of human KGF mRNA (KGF 3'-UTR mut), was then cloned into luciferase reporter plasmids. Human HSCs were co-transfected with 1μg miR-219-5p/null/as-miR-219-5p plasmids and 1μg human KGF 3'-UTR or human KGF 3'-UTR mut plasmids, after which the luciferase activity was measured. (D) The intact 3'-UTR of mouse KGF mRNA (KGF 3'-UTR), together with a 3'-UTR with mutant at miR-219-5p-binding site of mouse KGF mRNA (KGF 3'-UTR mut), was then cloned into luciferase reporter plasmids. Mouse HSCs were co-transfected with 1μg miR-219-5p/null/as-miR-219-5p plasmids and 1μg mouse KGF 3'-UTR or mouse KGF 3'-UTR mut plasmids, after which the luciferase activity was measured. *p<0.05. n=5. Statistics: oneway ANOVA with a Bonferroni correction. regulated by TGFβ in the setting of lung injury [33] [34] [35] [36] [37] . Ectopic expression of miR-155 in human fibroblasts induced modulation of a large set of associated genes including KGF. In vitro assays experimentally validated the functional target to 3'-UTR of KGF mRNA by miR-155, while in vivo experiments using a mouse model of lung fibrosis showed that miR-155 expression level was correlated with the degree of lung fibrosis [38] .
In the current study, we screened all KGF-targeting miRNAs and specifically found that the levels of miR-219-5p and KGF in the liver biopsies strongly and inversely correlated, suggesting the presence of miR-219-5p in fibrotic liver and a possible role of miR-219-5p in regulating KGF. Next, we confirmed that the modification of miR-219-5p indeed altered KGF level in both human and mouse HSCs. Since miRNAs normally target 3'-UTR of mRNA of a gene to inhibit its expression, we performed bioinformatics analysis and demonstrated a strong regulatory effect of miR-219-5p on KGF mRNA in both human and mouse HSCs, proven by luciferase assay.
Then we used a loss-of-function experiment to examine the effects of KGF activation by suppressing miR-219-5p in a mouse cirrhosis model. Compared with genetically modified mouse models for cirrhosis, a CCl 4 -induced model has some advantages in that it best resembles human liver fibrotic diseases [4] [5] [6] [7] [8] [9] . We administrated as-miR-219-5p through common bile duct, rather than through circulation. This viral delivery method is free from first by-pass effect, and is significantly lack of less off-target effects. Expression of antisense of miR-219-5p significantly attenuated the levels of liver fibrosis, portal hypertension and sodium retention caused by CCl 4 , seemingly through upregulation of KGF.
However, our data do not exclude a possibility that miR-219-5p may target genes other than KGF, which may also contribute to its effects during liver injury and recovery. Future 6 . Schematic of the model. Suppression of miR-219-5p increases KGF, which prevents the development of cirrhosis, and enhances liver regeneration.
